Biotechs Rapport and Telix throw their hats into IPO ring
Australian radiopharma developer Telix Pharma and US neuroscience specialist Rapport Therapeutics have become the latest biotechs to weigh in for initial public offerings
AstraZeneca unveils plan for $1.5bn ADC plant in Singapore
AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to ma
ATS: Vicore, Endeavor therapies show promise in IPF
Two experimental therapies from Vicore Pharma and Endeavor BioMedicines that could provide new ways of treating idiopathic pulmonary fibrosis (IPF) have shown encouraging
ATS: Amgen, AZ say data backs Tezspire’s role in COPD
Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have a role to play in chronic obstructive pulmonary disease (COPD) – a key target indication fo
Obesity drugs could bankrupt US healthcare, says Sanders
A report issued by the office of US Senator Bernie Sanders has claimed that the high prices being charged for new GLP-1 agonist-based obesity therapies like Novo Nordisk’s
Partner Content
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into
2nd mRNA Quality Control & Compliance Summit
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though
The 9th CAR-TCR Summit Returns to Boston!
The commercial success of cell therapies is continuing to grow!
Word Monster and the PM Society Join Forces to Elevate Medic...
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.
4th Next Generation Gene Therapy Vectors Summit 2024
Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston), the industry’s only hub for covering the latest advances and innovations in